DEVELOPMENT OF CLINICAL-GRADE, TARGETED MAGNETIC NANOPARTICLES

$559,414U54FY2008CANIH

Massachusetts Institute Of Technology, Cambridge MA

Investigators

Ralph Weissledercontact

Linked publications & trials

Paper 30500466 Paper 28193901 Paper 27792877 Paper 27098438 Paper 26490455 Paper 26267184 Paper 26258867 Paper 26102604 Paper 26098019 Paper 26089520 Paper 25985456 Paper 25650428 Paper 25289021 Paper 25230005 Paper 25221434 Paper 25214538 Paper 25119520 Paper 24932403 Paper 24887807 Paper 24824296 Paper 24220635 Paper 24177171 Paper 23969105 Paper 23835814 Paper 23832121 Paper 23808626 Paper 23713956 Paper 23697579 Paper 23656279 Paper 23377294 Paper 23339821 Paper 23225635 Paper 23042209 Paper 22983492 Paper 22909216 Paper 22896676 Paper 22764208 Paper 22762250 Paper 22584163 Paper 22408498 Paper 22376183 Paper 22337601 Paper 22272219 Paper 22268625 Paper 22201893 Paper 22185195 Paper 22113800 Paper 22020333 Paper 21987724 Paper 21981330 Paper 21977404 Paper 21888516 Paper 21780311 Paper 21685903 Paper 21547317 Paper 21495138 Paper 21433105 Paper 21346169 Paper 21317907 Paper 21245339 Paper 21233423 Paper 21187397 Paper 21123946 Paper 20949198 Paper 20921363 Paper 20886481 Paper 20859943 Paper 20836539 Paper 20814923 Paper 20726522 Paper 20689678 Paper 20677297 Paper 20625581 Paper 20625468 Paper 20518524 Paper 20481508 Paper 20394530 Paper 20387142 Paper 20336708 Paper 20231381 Paper 20228787 Paper 20217810 Paper 20217526 Paper 20174478 Paper 20166699 Paper 20148638 Paper 20133865 Paper 20080556 Paper 20028085 Paper 20025223 Paper 20025222 Paper 20025010 Paper 20023731 Paper 19893516 Paper 19850333 Paper 19812695 Paper 19801750 Paper 19713582 Paper 19697933 Paper 19675897

View original record on NIH RePORTER →